After three months of corticosteroid treatment, a sixty-nine-year-old man, suffering from temporal arteritis, developed a Kaposi's sarcoma (KS) initially located on the left ankle and subsequently spread over both feet and hands. Laboratory data showed a deficiency of both humoral and cellular immunity and constant positivity in the tests for cytomegalovirus.
The onset of KS during corticosteroid treatment of temporal arteritis is an extremely rare occurrence, this case being only the second one reported in the literature.
In our case the development of this neoplasm can be related to an immunodeficiency that led to a deficit in the immunological surveillance, along with an activation of oncogenic viruses.
Get full access to this article
View all access options for this article.
References
1.
Leung F., Fam AG, Osoba D.: Kaposi's sarcoma complicating corticosteroid therapy for temporal arteritis . Am J Med71:320-322, 1981.
2.
Fiala M., Payne JE, Berne TV et al: Epidemiology of cytomegalovirus infection after transplantation and immunosuppression. J Infect Dis132:421-432, 1975.
3.
Giraldo G., Beth E., Henle W., et al: Antibody patterns to herpesviruses in Kaposi's sarcoma. II. Serological association of American Kaposi's sarcoma with cytomegalovirus . Int J Cancer22:126-131, 1978.
4.
Drew WL, Miner RC, Ziegler JL, et al: Cytomegalovirus and Kaposi's sarcoma in young homosexual men . The Lancet, July 17, 125-127, 1982.
5.
Master S., Taylor JF, Kyalwazi SK, et al: Immunological studies in Kaposi's sarcoma in Uganda. Br Med J1:600, 1970.
Mazzaferri EL , Penn GM: Kaposi's sarcoma associated with multiple myeloma. Arch Intern Med122:521, 1968.
8.
Safai B., Mike V., Giraldo G., et al: Association of Kaposi's sarcoma with second primary malignancies. Possible etiopathogenic implications. Cancer45:1472, 1980.
9.
Moskowitz LB, Hensley GT, Gould EW, et al: Frequency and anatomic distribution of lymphadenopathic Kaposi's sarcoma in the acquired immunodeficiency syndrome. An autopsy series. Human Pathol16(5):447-456, 1985.
10.
Weiss VC, Serushan M.: Kaposi's sarcoma in a patient with dermatomyositis receiving immunosuppressive therapy. Arch Dermatol118:3, 1982.
11.
Klein MB, Pereira FA, Kantor I.: Kaposi's sarcoma complicating systemic lupus erythematosus treated with immunosuppression . Arch Dermatol110:602, 1974.
12.
Brooke MH, Kaplan H.: Muscle pathology in rheumatoid arthritis, polymyalgia rheumatica, and polymyositis. A histochemical study. Arch Pathol Lab Med94:101-118, 1972.
13.
Harwood AR, Osoba D., Hofstader SL, et al: Kaposi's sarcoma in recipients of renal transplants. Am J Med67:759, 1979.
14.
Penn I.: Kaposi's sarcoma in organ transplant recipients. Report of 20 cases. Transplantation27:8, 1979.
15.
Klepp O., Dahl O., Stenwig JT: Association of Kaposi's sarcoma and prior immunosuppressive therapy. A 5-year material of Kaposi's sarcoma in Norway. Cancer42:2626, 1978.
16.
Gange RW, Wilson-Jones E.: Kaposi's sarcoma and immunosuppression therapy. An appraisal. Clin Exp Dermatol3:135, 1978.
17.
Hazleman B. , Goldsone A., Voak D.: Association of polymyalgia rheumatica and giant-cell arteritis with HLA-B8. Br Med J2:989, 1977.
18.
Rosenthal M. , Muller W., Albert ED, et al: HLA antigens in polymyalgia rheumatica . N Engl J Med292:595, 1975.
19.
Pollack MS, Safai B., Myscowski PI, et al: Frequencies of HLA and Gm immunogenetic markers in Kaposi's sarcoma. Tissue Antigens21:1, 1983.
20.
Friedman-Kien, AE, Laubenstein LJ, Rubinstein P., et al: Disseminated Kaposi's sarcoma in homosexual men. Ann Intern Med96:693, 1982.
21.
Papasteriades C., Kaloterakis A., Filiotou A., et al: Histocompatibility antigens HLA-A, B, DR in Greek patients with Kaposi's sarcoma. Tissue Antigens24:313, 1984.
